blue shield of california glp 1 coverage Insurance Tips for GLP-1 Obesity Medications GLP-1 Insurance Coverage Statistics 2026

Sheli Agarwal M.D

December 20 Product: Vertex Pharmaceuticals Alyftrek Indication: Adults and children aged 6 and up with cystic fibrosis and at least one F508del mutation or another mutation in the CFTR gene that is responsive to the treatment Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product Alyftrek, clearing the biotech to market a product designed to improve on Trikafta

This includes explaining how these drugs slow gastric emptying, which can lead to symptoms of gastroparesis

The charity Melanoma Fund also warns that Melanotan is linked with a higher risk of melanoma, a type of skin cancer